The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan agreement and related party transaction

22 Jan 2020 07:00

RNS Number : 5064A
Plutus PowerGen PLC
22 January 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Plutus PowerGen Plc / Ticker: PPG / Index: AIM

22 January 2020

PLUTUS POWERGEN PLC

("Plutus", the "Group" or the "Company")

 

Loan agreement and related party transaction

 

The Company announces that, on 21 January 2020, it entered into an agreement with Charles Tatnall (Executive Chairman) and James Longley (Interim Chief Executive Officer and Chief Financial Officer) for an unsecured loan facility (the "Loan") of up to £150,000 (the "Loan Agreement").

 

As previously announced the Company's working capital position is highly constrained. The Loan will be used to meet the Company's short-term working capital needs. Following entering into the Loan Agreement the Company expects to be able to meet its liabilities as they fall due until mid-May 2020. As announced on 31 October 2019 the Company has implemented a cost control strategy including board members not drawing salaries and the Board remains confident that the Company would be able to raise further funds in addition to the Loan to enable the Company's debts to be paid as they fall due, should the need arise.

 

The Loan will be provided in equal amounts of £75,000 from each of the lenders (being Charles Tatnall and James Longley) and will be drawn down by the Company in four tranches of £18,750 from each lender. The first tranche totalling £37,500 is expected to be drawn down in full by the Company by 31 January 2020 with the subsequent three loan instalments, each totalling £37,500, expected to be drawn down in full by the Company by 29 February 2020, 31 March 2020 and 30 April 2020 respectively.

 

The Loan carries interest on the principal amount outstanding from time to time at the rate of 10 per cent. per annum. The accrued interest shall be rolled up and repaid in cash at the time of the repayment of the outstanding principal under the Loan Agreement.

 

The arrangement can be terminated at any time by either the Company or the lenders. The outstanding principal and accrued interest on the Loan will be repayable on demand with a 21 day notice of repayment. Such notice of repayment can be requested by the lenders at any time from the date of the Loan Agreement including prior to all the Loan instalments having been made by the lenders under the Loan Agreement. Furthermore, the Loan is repayable within 21 days upon a change of control of the existing board of the Company (being Charles Tatnall, James Longley and Tim Cottier) unless such repayment obligation is waived by the lenders.

 

In the event that the lenders sought repayment of the amounts outstanding on the Loan, and in the absence of the Company having raised capital from elsewhere and/or generated cash from its existing operations, the Company would be required to raise further funds from other sources to address the Company's working capital position. There can be no guarantee that, should the need arise, the Company will be able to raise further funding to address any potential future working capital shortfall.

 

Charles Tatnall and James Longley are directors of and substantial shareholders in the Company. Therefore, the entering into of the Loan Agreement constitutes a related party transaction under Rule 13 of the AIM Rules for Companies. Tim Cottier, Non-Executive Director of the Company and the independent director for the purposes of the transaction, considers, having consulted with Allenby Capital Limited, the Company's nominated adviser, that the terms of the Loan Agreement are fair and reasonable insofar as the Company's shareholders are concerned.

 

**ENDS**

 

 For further information, please visit www.plutuspowergen.com, or contact:

 

Plutus PowerGen Plc

+44 (0) 20 8720 6562

Charles Tatnall, Executive Chairman

Allenby Capital Limited (Nominated Adviser and Joint Broker)

+44 (0)20 3328 5656

Nick Athanas

James Hornigold

Turner Pope Investments (TPI) Limited (Joint Broker)

+44 (0)20 3621 4120

Andy Thacker

St Brides Partners Limited (Financial PR)

+44 (0)20 7236 1177

Isabel de Salis

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSEEFWFESSELF
Date   Source Headline
15th Oct 20121:00 pmRNSDisposal
10th Oct 20127:30 amRNSStatement re. Suspension
10th Oct 20127:30 amRNSSuspension - IPSO Ventures Plc
29th Aug 20127:00 amRNSHolding(s) in Company
10th Aug 20127:00 amRNSDirector/PDMR Shareholding
3rd Aug 201212:40 pmRNSReplacement - Director Shareholding
3rd Aug 20127:00 amRNSDirector/PDMR Shareholding
15th Jun 20127:00 amRNSHolding(s) in Company
18th Apr 20127:00 amRNSDirector/PDMR Shareholding
29th Feb 20127:00 amRNSTotal Voting Rights
8th Feb 20127:00 amRNSIssue of equity, directors' shareholdings and TVR
23rd Jan 20127:01 amRNSHalf Yearly Report
17th Jan 20124:30 pmRNSHolding(s) in Company
30th Nov 20117:00 amRNSTotal Voting Rights
18th Nov 20117:00 amRNSIssue of Equity
14th Nov 20112:00 pmRNSDirector/PDMR Shareholding
1st Nov 20114:20 pmRNSChange of Registered Office
24th Oct 20117:00 amRNSAIM Rule 17 Disclosures
12th Oct 20117:00 amRNSIPSol Energy successful fund raising
3rd Oct 20115:15 pmRNSHolding(s) in Company
30th Sep 201110:00 amRNSTotal Voting Rights
30th Sep 20119:00 amRNSHolding(s) in Company
22nd Sep 20111:50 pmRNSHolding(s) in Company
15th Sep 20112:15 pmRNSEU grants approval for Buccolam
9th Sep 20111:00 pmRNSResult of AGM
25th Aug 20111:35 pmRNSIssue of Equity and Director Dealings
19th Aug 20117:00 amRNSFinal Results
8th Aug 20117:00 amRNSDirectorate Changes
12th Jul 20117:00 amRNSTermination of Loughborough University agreement
7th Jul 201110:35 amRNSCompletion of placing to raise £195,000
1st Jul 20117:00 amRNSTherakind Product Update
29th Jun 20111:05 pmRNSResult of General Meeting
27th Jun 20117:00 amRNSFurther re General Meeting
24th Jun 20117:00 amRNSHolding(s) in Company
22nd Jun 20114:58 pmRNSHolding(s) in Company
22nd Jun 20117:00 amRNSShareholding in Biocroi
13th Jun 20113:50 pmRNSProposed Placing to raise £195,000/Notice of GM
25th May 20115:10 pmRNSHolding(s) in Company
24th May 20117:00 amRNSCambridge Meditech agreement with Lantor (UK)
25th Mar 20117:00 amRNSTrading update
11th Feb 20117:00 amRNSHolding(s) in Company
8th Feb 20111:30 pmRNSHolding(s) in Company
26th Jan 20113:30 pmRNSHolding(s) in Company
5th Jan 20117:00 amRNSHalf Yearly Report
8th Oct 20103:15 pmRNSDirector/PDMR Shareholding
8th Oct 20108:00 amRNSDirectorate Change
13th Sep 20107:00 amRNSAllotment of Adviser Shares
10th Sep 201012:30 pmRNSResult of AGM
27th Aug 201012:20 pmRNSResult of General Meeting
20th Aug 20107:00 amRNSPosting of Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.